New pain combo could cut opioid use after stoma surgery
NCT ID NCT07368075
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested two different drug combinations for pain relief after stoma reversal surgery. 86 adults received either ropivacaine plus dexamethasone or ropivacaine plus dexmedetomidine in a nerve block. The goal was to see which combination provides longer pain relief and reduces the need for opioids. The trial is already completed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ropivacaine plus dexamethasone or ropivacaine plus dexmedetomidine
- What this could lead to
- If successful, this could point to a better way to manage pain after abdominal surgery, reducing the need for opioids and their side effects.
- What could go wrong
- This is a small, completed trial with only 86 participants, so results may not apply to everyone. The study compares two existing drugs, so no new treatment is being developed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sahiwal Medical College
Sāhīwāl, Punjab Province, 57000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a laser beam replace opioids for knee surgery pain?
- Can skipping opioids during surgery improve recovery?
- Can a safer nerve block match the gold standard for Post-Mastectomy pain?
- Can a new device make pacemaker placement more precise?
- Painkiller form may matter after gastric bypass
- Pacemaker tweak may also lower blood pressure